Coming out of second quarter earnings, it's as clear as ever that surgical robot company Intuitive Surgical (ISRG)
does not have the luxury of being casual about driving wider adoption
of its daVinci robotic surgical system. While the U.S. prostatectomy
market is not going to disappear, the multiples on this stock leave
almost no room for disappointment and declines in this long-time core
market are starting to weigh on procedure volumes.
Continue here to the full article:
Can Intuitive Surgical Drive Wider Adoption Fast Enough To Maintain Multiples?
No comments:
Post a Comment